
Broadway Financial Corporation: updates and filings
Price
$10.84
November 19, 2026Market cap $93M
What Ploutos Investor adds for Broadway Financial
Part of Ploutos Investor, €9.99 a month
- The full history: 16 fiscal years, from 2010
- The estimated fair value, with its range and its certainty
- The full analysis, 18 a month
- More questions to the chat on its filings
- Excel with every year
- An email when it reports, changes its dividend or an officer buys
Sign in with a free account to see the last 5 fiscal years.
Notes on these figures
- Earnings per share here are the last twelve months' earnings over today's shares, so they agree with the P/E. The number of shares changed a lot during the year, so they differ from the earnings per share the company filed, which use the year's average number of shares.
What comes next, and what happened
Its next results and latest dividend, and the filings that told of something: results, deals, people, debt. In plain words, each linked to the filing.
Next results
last Nov 13, 2026next Jan 28, 2027
An estimate from when it has reported before, and the timing has varied a little. The company announces the date itself.
November 2026
October 2026
May 2026
Its SEC filings
What it has filed lately, newest first, linked to the document itself.
- Nov 13, 2026Quarterly reportfor the period to Sep 30, 2026Form10-Q
- Nov 13, 2026Results of operations, Regulation FD disclosureForm8-K
- Oct 2, 2026Officer or director changeForm8-K
- Aug 13, 2026Quarterly reportfor the period to Jun 30, 2026Form10-Q
- Aug 11, 2026Over-5% holder statement (passive) (amendment)FormSCHEDULE 13G/A
- Jul 28, 2026Results of operations, Regulation FD disclosureForm8-K
- Jun 23, 2026Shareholder vote, Regulation FD disclosureForm8-K
- Jun 18, 2026Regulation FD disclosureForm8-K
- Jun 3, 2026Regulation FD disclosureForm8-K
- May 15, 2026Quarterly reportfor the period to Mar 31, 2026Form10-Q
- May 15, 2026Results of operations (amendment)Form8-K/A
- Apr 30, 2026Annual report to shareholdersfor the period to Dec 31, 2025FormARS
- Apr 30, 2026Additional annual meeting materialFormDEFA14A
- Apr 30, 2026Annual meeting proxy statementFormDEF 14A
- Apr 29, 2026Over-5% holder statement (passive)FormSCHEDULE 13G
- Apr 28, 2026Results of operationsForm8-K
- Mar 31, 2026Annual reportfor the period to Dec 31, 2025Form10-K
- Mar 26, 2026Over-5% holder statement (passive) (amendment)FormSCHEDULE 13G/A
- Feb 26, 2026Other material eventsForm8-K
- Feb 18, 2026Regulation FD disclosureForm8-K
- Feb 13, 2026Quarterly reportfor the period to Sep 30, 2025Form10-Q
- Dec 31, 2025Quarterly reportfor the period to Jun 30, 2025Form10-Q
- Dec 31, 2025Quarterly report (amendment)for the period to Mar 31, 2025Form10-Q/A
- Dec 23, 2025Annual report (amendment)for the period to Dec 31, 2024Form10-K/A
- Dec 18, 2025Over-5% holder statement (passive)FormSCHEDULE 13G
| Filed | Form | What it is | Filing |
|---|---|---|---|
| Nov 13, 2026 | 10-Q | Quarterly reportfor the period to Sep 30, 2026 | Document |
| Nov 13, 2026 | 8-K | Results of operations, Regulation FD disclosure | Document |
| Oct 2, 2026 | 8-K | Officer or director change | Document |
| Aug 13, 2026 | 10-Q | Quarterly reportfor the period to Jun 30, 2026 | Document |
| Aug 11, 2026 | SCHEDULE 13G/A | Over-5% holder statement (passive) (amendment) | Document |
| Jul 28, 2026 | 8-K | Results of operations, Regulation FD disclosure | Document |
| Jun 23, 2026 | 8-K | Shareholder vote, Regulation FD disclosure | Document |
| Jun 18, 2026 | 8-K | Regulation FD disclosure | Document |
| Jun 3, 2026 | 8-K | Regulation FD disclosure | Document |
| May 15, 2026 | 10-Q | Quarterly reportfor the period to Mar 31, 2026 | Document |
| May 15, 2026 | 8-K/A | Results of operations (amendment) | Document |
| Apr 30, 2026 | ARS | Annual report to shareholdersfor the period to Dec 31, 2025 | Document |
| Apr 30, 2026 | DEFA14A | Additional annual meeting material | Document |
| Apr 30, 2026 | DEF 14A | Annual meeting proxy statement | Document |
| Apr 29, 2026 | SCHEDULE 13G | Over-5% holder statement (passive) | Document |
| Apr 28, 2026 | 8-K | Results of operations | Document |
| Mar 31, 2026 | 10-K | Annual reportfor the period to Dec 31, 2025 | Document |
| Mar 26, 2026 | SCHEDULE 13G/A | Over-5% holder statement (passive) (amendment) | Document |
| Feb 26, 2026 | 8-K | Other material events | Document |
| Feb 18, 2026 | 8-K | Regulation FD disclosure | Document |
| Feb 13, 2026 | 10-Q | Quarterly reportfor the period to Sep 30, 2025 | Document |
| Dec 31, 2025 | 10-Q | Quarterly reportfor the period to Jun 30, 2025 | Document |
| Dec 31, 2025 | 10-Q/A | Quarterly report (amendment)for the period to Mar 31, 2025 | Document |
| Dec 23, 2025 | 10-K/A | Annual report (amendment)for the period to Dec 31, 2024 | Document |
| Dec 18, 2025 | SCHEDULE 13G | Over-5% holder statement (passive) | Document |
From the company's record at the SEC (EDGAR). The topics of each 8-K are the item codes the company itself filed. Its whole record at the SEC, since May 15, 1996.
The full analysis
What do Broadway Financial's filings show?
The filings are where every one of Broadway Financial's figures comes from. The full Ploutos AI analysis reads everything the company has filed and shows what stands behind it, with a source for every figure.
- A fair value range built from the filings
- Earnings quality, debt and red flags
- Insider and institutional moves
- The case for and the case against
Related pages
The other pages on US stocks, free to read. On the company pages, the last three fiscal years are open to everyone, five with a free account, and every year with Ploutos Investor.
The figures come from the company's SEC filings and the share price, and describe what it has reported. They are not a score or a fair value.